FDA’s latest move to integrate patient input into regulatory decision-making on drugs, devices and biologics is a May 18 meeting to be held at the agency’s White Oak, Silver Spring, Md. headquarters.
The agency says it will welcome patients, caregivers, independent patient advocates, patient advocate groups, academics, industry representatives and health professional groups to the meeting. FDA will use the occasion to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?